TELA Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

TELA Bio, a commercial-stage medical technology company, has announced its participation in two investor conferences. TELA’s management will present virtually at the H.C. Wainwright Annual Global Investment Conference on September 12, 2022, at 7:00 AM ET. Additionally, they will take part in the Lake Street BIG6 1x1 Conference on September 14, 2022. TELA Bio focuses on innovative soft-tissue reconstruction solutions that prioritize patient anatomy preservation. The company is committed to enhancing clinical outcomes while reducing reliance on synthetic materials.

MALVERN, Pa., Sept. 01, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that it will participate in two upcoming investor conferences.

TELA Bio’s management is scheduled to present virtually at the H.C. Wainwright Annual Global Investment Conference. Interested parties can access the archived webcast at ir.telabio.com on Monday, September 12^th, 2022, at 7:00am ET.

TELA Bio’s management will also be participating in the Lake Street BIG6 1x1 Conference on Wednesday, September 14^th, 2022.

About TELA Bio, Inc.

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
332-895-3230
ir@telabio.com

FAQ

What is TELA Bio's participation in the H.C. Wainwright Annual Global Investment Conference?

TELA Bio will present virtually at the H.C. Wainwright Annual Global Investment Conference on September 12, 2022, at 7:00 AM ET.

When is TELA Bio attending the Lake Street BIG6 1x1 Conference?

TELA Bio will participate in the Lake Street BIG6 1x1 Conference on September 14, 2022.

What are TELA Bio's core focuses as a medical technology company?

TELA Bio focuses on innovative soft-tissue reconstruction solutions that optimize clinical outcomes while prioritizing the preservation of the patient's own anatomy.

What is the stock symbol for TELA Bio?

TELA Bio is traded under the stock symbol TELA on the NASDAQ.